Literature DB >> 16717223

Fixation-sensitive myoclonus in Lafora disease.

S Kumada1, M Kubota, M Hayashi, A Uchiyama, K Kurata, Y Kagamihara.   

Abstract

The authors report a patient with Lafora disease, whose myoclonus was suppressed by passive eye closure. Neurophysiologic studies disclosed that fixation was the most important enhancer of myoclonus. Magnetoencephalographic studies of visual evoked fields revealed abnormal activation of the visual corticocortical pathway via the insular cortex not seen in controls. The authors hypothesize that abnormal activation of the insular cortex may be involved in triggering the mechanism of fixation-sensitive myoclonus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16717223     DOI: 10.1212/01.wnl.0000216147.12172.39

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  Lafora disease: epidemiology, pathophysiology and management.

Authors:  Thomas S Monaghan; Norman Delanty
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

Review 2.  Update on Pharmacological Treatment of Progressive Myoclonus Epilepsies.

Authors:  Edoardo Ferlazzo; Dorothee Kasteleijn-Nolst Trenite; Gerrit-Jan de Haan; Felix Felix Nitschke; Saija Ahonen; Sara Gasparini; Berge A Minassian
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

3.  Coexistence of fixation-off sensitivity and inverted fixation-off sensitivity in a female child with Panayiotopoulos syndrome: Video-electroencephalography documentation.

Authors:  Imad Y Saadeldin; Hussein N Matlik
Journal:  Epilepsy Behav Case Rep       Date:  2015-05-28

4.  Case Report: Distinctive EEG Patterns in SCARB-2 Related Progressive Myoclonus Epilepsy.

Authors:  Mostafa Hotait; Maya Dirani; Tarek El Halabi; Ahmad Beydoun
Journal:  Front Genet       Date:  2020-12-03       Impact factor: 4.599

5.  Structural and Functional Brain Abnormalities in Mouse Models of Lafora Disease.

Authors:  Daniel F Burgos; Lorena Cussó; Gentzane Sánchez-Elexpuru; Daniel Calle; Max Bautista Perpinyà; Manuel Desco; José M Serratosa; Marina P Sánchez
Journal:  Int J Mol Sci       Date:  2020-10-20       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.